News

Two different types of rehabilitation-focused exercise programs — activity-based training and strength exercises — improved measures of dexterity and upper limb function in a small clinical trial of people with Parkinson’s disease. The study, “Effect of Activity-Based Training Versus Strengthening Exercises on Upper Extremity Functions in Parkinson’s Patients; A…

A Stanford University research initiative will focus on the causes of neurodegeneration in diseases such as Parkinson’s and on the mechanisms behind some people’s brain resilience to aging and neurodegeneration. This information will be used to find ways to prevent, delay, or even reverse neurodegeneration and cognitive decline. “This…

People with Parkinson’s disease who have higher levels of vitamin D in their blood are less likely to experience cognitive impairment or dementia, a new study suggests. The results provide support for future research to test whether vitamin D supplements could reduce the risk of cognitive problems for Parkinson’s…

Alpha Motor Corporation, an electric vehicle company based in Irvine, California, will donate 100% of net proceeds of sales from its NFT fundraiser to the Michael J. Fox Foundation for Parkinson’s Research (MJFF) in support of its research programs advancing work into Parkinson’s disease. The online event features…

UB-312, an experimental vaccine targeting aggregated and toxic forms of alpha-synuclein to treat Parkinson’s disease, was generally well tolerated at multiple doses in a clinical trial in healthy adults. Study data also suggest that UB-312 prompted an immune response, as designed, against the alpha-synuclein protein. With two doses now selected…

Damage to certain nerve fibers in the extremities, known as peripheral neuropathy, was evident in some people with Parkinson’s disease, including those at early disease stages, a study reported. Findings in this work, which used a sensitive electrophysiological device to examine nerves, also suggested that peripheral neuropathy was related…

WCG IRB will now serve as the institutional review board (IRB) for the Michael J. Fox Foundation’s (MJFF) ongoing Parkinson’s Progression Markers Initiative (PPMI) study, WCG announced. The PPMI study (NCT04477785), renamed PPMI 2.0 in July 2020, is a longitudinal, observational study of individuals with and without…

PreciseDx’s artificial intelligence (AI) platform shows an ability to accurately diagnose Parkinson’s disease in people before they develop severely evident symptoms, according to a new study. Conducted in collaboration with The Michael J. Fox Foundation (MJFF), the study’s findings support the platform’s potential to aid in diagnosing Parkinson’s and allowing patients to begin…

A research team in Canada is embarking on a project that will apply MRI to identify new biomarkers for diagnosing Parkinson’s disease and monitoring its progression over time. The potential findings may speed Parkinson’s diagnoses and help patients receive treatment sooner. Identifying easily recognizable MRI signatures of Parkinson’s could…

The Riverside Health & Rehabilitation Center, an affiliate of National Health Care Associates, now has a comprehensive program aimed at improving physical health and cognition for those with Parkinson’s disease. The program, housed at Riverside’s facility in East Hartford, Connecticut, is also open for people…